These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8728650)

  • 1. Use of macromolecular assemblies as expression systems for peptides and synthetic vaccines.
    Lomonossoff GP; Johnson JE
    Curr Opin Struct Biol; 1996 Apr; 6(2):176-82. PubMed ID: 8728650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic peptide epitope-based polymers: controlling size and determining the efficiency of epitope incorporation.
    Sadler K; Zeng W; Jackson DC
    J Pept Res; 2002 Sep; 60(3):150-8. PubMed ID: 12213124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral peptide immunogens: current challenges and opportunities.
    Azizi A; Diaz-Mitoma F
    J Pept Sci; 2007 Dec; 13(12):776-86. PubMed ID: 17853502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships in peptide-antibody complexes: implications for epitope prediction and development of synthetic peptide vaccines.
    Chen SW; Van Regenmortel MH; Pellequer JL
    Curr Med Chem; 2009; 16(8):953-64. PubMed ID: 19275605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering and evaluation of amyloid assemblies as a nanovaccine against the Chikungunya virus.
    Babych M; Bertheau-Mailhot G; Zottig X; Dion J; Gauthier L; Archambault D; Bourgault S
    Nanoscale; 2018 Nov; 10(41):19547-19556. PubMed ID: 30324958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-core-peptide system for self-adjuvanting synthetic vaccine delivery.
    Skwarczynski M; Toth I
    Methods Mol Biol; 2011; 751():297-308. PubMed ID: 21674338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Method for the synthesis of highly pure vaccines using the lipid core peptide system.
    Moyle PM; Olive C; Good MF; Toth I
    J Pept Sci; 2006 Dec; 12(12):800-7. PubMed ID: 17131293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of chimeric vaccines constructed with PEP-1 and Ii-Key linking to a hybrid epitope from heterologous viruses.
    Liu XL; Shan WJ; Xu SS; Zhang JJ; Xu FZ; Xia SL; Dai Y
    Biologicals; 2015 Sep; 43(5):377-82. PubMed ID: 26153399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein Epitope Mimetics: From New Antibiotics to Supramolecular Synthetic Vaccines.
    Zerbe K; Moehle K; Robinson JA
    Acc Chem Res; 2017 Jun; 50(6):1323-1331. PubMed ID: 28570824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic peptides as vaccines.
    Arnon R; Horwitz RJ
    Curr Opin Immunol; 1992 Aug; 4(4):449-53. PubMed ID: 1382452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hepatitis nucleocapsid as a vaccine carrier moiety.
    Milich DR; Peterson DL; Zheng J; Hughes JL; Wirtz R; Schödel F
    Ann N Y Acad Sci; 1995 May; 754():187-201. PubMed ID: 7542855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technological advances in antigen delivery and synthetic peptide vaccine developmental strategies.
    Olive C; Toth I; Jackson D
    Mini Rev Med Chem; 2001 Nov; 1(4):429-38. PubMed ID: 12369968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
    Schödel F; Peterson D; Milich D
    Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic properties of HCMV peptides displayed by filamentous bacteriophages vs. synthetic peptides.
    Ulivieri C; Citro A; Ivaldi F; Mascolo D; Ghittoni R; Fanigliulo D; Manca F; Baldari CT; Li Pira G; Del Pozzo G
    Immunol Lett; 2008 Aug; 119(1-2):62-70. PubMed ID: 18538862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-peptides as immunogens and diagnostic reagents.
    Van Regenmortel MH; Muller S
    Curr Opin Biotechnol; 1998 Aug; 9(4):377-82. PubMed ID: 9720264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How can peptide vaccines work?
    Rowlands DJ
    FEMS Microbiol Lett; 1992 Dec; 100(1-3):479-81. PubMed ID: 1282484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The canine MHC class Ia allele DLA-88*508:01 presents diverse self- and canine distemper virus-origin peptides of varying length that have a conserved binding motif.
    Ross P; Nemec PS; Kapatos A; Miller KR; Holmes JC; Suter SE; Buntzman AS; Soderblom EJ; Collins EJ; Hess PR
    Vet Immunol Immunopathol; 2018 Mar; 197():76-86. PubMed ID: 29475511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidation of T-cell epitopes: a synthetic approach with random peptide libraries.
    Walden P; Wiesmüller KH; Jung G
    Biochem Soc Trans; 1995 Aug; 23(3):678-81. PubMed ID: 8566442
    [No Abstract]   [Full Text] [Related]  

  • 19. Dissecting the role of peptides in the immune response: theory, practice and the application to vaccine design.
    Purcell AW; Zeng W; Mifsud NA; Ely LK; Macdonald WA; Jackson DC
    J Pept Sci; 2003 May; 9(5):255-81. PubMed ID: 12803494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide based cytotoxic T-cell vaccines; delivery of multiple epitopes, help, memory and problems.
    Elliott SL; Pye S; Le T; Mateo L; Cox J; Macdonald L; Scalzo AA; Forbes CA; Suhrbier A
    Vaccine; 1999 Apr; 17(15-16):2009-19. PubMed ID: 10217601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.